This project will validate a proprietary vaccine platform using a COVID-19 pilot study.
Eyam Vaccines and Immunotherapeutics Ltd.
5 records totalling $484,905.50 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $482,400 | 4 records |
| Employment and Social Development Canada | $2,506 | 1 record |
Records
The goal of this project is to test a proprietary in silico platform and vector system to design and validate vaccine formulations targeting Influenza and SARS-CoV-2.
This International Co-Innovation Action Program (ICAP) project will prepare the firm to enter into future international co-innovation work.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Rese...
Through the application of national and local priorities, the CSJ program seeks to provide youth, particularly those who face barriers to employment with access to work opportunities. Funded employers...